Targeted Therapies Could Make Rx Companies More Credible, Lilly Exec Says
Executive Summary
A move to more targeted therapies could improve trust of the pharmaceutical industry, Lilly New Product Planning Director Maureen Kiley told a Cambridge Healthtech Institute conference on targeted therapeutics